Skip to main content

Table 3 LVAD management (continuous flow, centrifugal pump)

From: Anesthetic management for withdrawal from a right ventricular assist device and Fontan procedure in a patient with an implantable left ventricular assist device for fulminant cardiomyopathy

ăƒ»TEE

Orientation of inflow cannula: perpendicular to mitral valve

 

PFO: Draws blood flow from the right ventricular system into the lef

t ventricular system after VAD drive

MR: Left ventricular chamber is smaller after VAD drive, MR may be

AR: Aortic valvuloplasty recommended if more than mild (Feldman)

AS: Valve replacement recommended regardless of the stage

TR: Tricuspid valve plasty is recommended in cases of moderate or severe valve ring enlargement

MS: Less frequent, but if present, mitral valvuloplasty is recommended

Air in left ventricular: prevent air emboli

Ventricular septal deviation (see below)

ăƒ»Blood pressure

Target: 65–75 mmHg

 < 60 mmHg: coronary return pressure decreases and right heart function declines

 > 80 mmHg: greater lift and reduced VAD flow

ăƒ»Ventricular septum shift

Right shift (possibility of pulmonary congestion)

Increase VAD rpm, check for AR and inflow cannula, blood pressure optimization

Leftward shift (possibility of sucking down event)

Decrease VAD rpm, check for inflow cannula, blood pressure optimization

Correction of hypovolemia, use of inotropic drugs or NO

  1. LVAD Left ventricular assist device, TEE Transesophageal echocardiography, SVC Superior vena cava, IVC Inferior vena cava, PFO Patent foramen ovale, MR Mitral regurgitation, AR Aortic regurgitation, AS Aortic stenosis, TR Tricuspid regurgitation, MS Mitral stenosis, VAD Ventricular assist device, rpm revolutions per minute, NO Nitric oxide